CoChat

Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies

Tasaka, Sadatomo, Tokuda, Hitoshi · 2012 · Journal of Infection and Chemotherapy

The DOI matches its Crossref record; 117 of the 119 references it cites were found in a registry or an index.

Abstract

In human immunodeficiency virus (HIV)-infected patients, Pneumocystis jirovecii pneumonia (PCP) is a well-known opportunistic infection, and its management has been established. However, PCP is an emerging threat to immunocompromised patients without HIV infection, such as those receiving novel immunosuppressive therapeutics for malignancy, organ transplantation, or connective tissue diseases. Clinical manifestations of PCP are quite different between patients with and without HIV-infections. In patients without HIV infection, PCP rapidly progresses, is difficult to diagnose correctly, and causes severe respiratory failure with a poor prognosis. High-resolution computed tomography findings are different between PCP patients with HIV infection and those without. These differences in clinical and radiologic features are the result of severe or dysregulated inflammatory responses that are evoked by a relatively small number of Pneumocystis organisms in patients without HIV infection. In recent years, the usefulness of PCR and serum β-D-glucan assay for rapid and noninvasive diagnosis of PCP has been revealed. Although corticosteroid adjunctive to anti-Pneumocystis agents has been shown to be beneficial in some populations, the optimal dose and duration remain to be determined. Recent investigations revealed that Pneumocystis colonization is prevalent, and that asymptomatic carriers are at riskfor developing PCP and can serve as the reservoir for the spread of Pneumocystis by person-to-person transmission. These findings suggest the need for chemoprophylaxis in immunocompromised patients without HIV infection, although its indication and duration are still controversial. Because a variety of novel immunosuppressive therapeutics have been emerging in medical practice, further innovations in the diagnosis and treatment of PCP are needed.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10156-012-0453-0

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 117 references

Cited by

See all 135

Metadata

Authors
Tasaka, S., & Tokuda, H.
Affiliations
Keio University (JP)
Corresponding author
Tasaka, Sadatomo
Venue
Journal of Infection and Chemotherapy
Publisher
Elsevier BV
Published
2012
Volume
18
Issue
6
Pages
793-806
ISSN
1341-321X (ISSN-L)
OpenAlex
W2105078649
Cited by
123
References
119
Citations by year
2026: 3 · 2025: 6 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 10 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 9 · 2016: 19 · 2015: 13 · 2014: 17 · 2013: 4 · 2012: 1
FWCI
1.40
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Journal of Infection and Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
Pneumocystis carinii pneumonia, non-HIV immunocompromised patients, opportunistic infections, high-resolution computed tomography, PCR diagnosis, Pneumocystis colonization, asymptomatic carriers, chemoprophylaxis, organ transplantation, hematologic malignancies, connective tissue diseases, respiratory failure
MeSH terms
Humans, Immunocompetence, Immunosuppressive Agents, Pneumonia, Pneumocystis, HIV Infections, Communicable Diseases, Emerging, Pneumocystis carinii

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. https://app.cochat.ai/papers/10.1007/s10156-012-0453-0
The paper
Tasaka, S., & Tokuda, H. (2012). Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. Journal of Infection and Chemotherapy. https://doi.org/10.1007/s10156-012-0453-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.